beta
/SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)